Le Lézard
Classified in: Health, Science and technology, Business
Subject: SBS

Kineta Invited to Participate at the Cowen and Company 40th Annual Health Care Conference


SEATTLE, Feb. 27, 2020 /PRNewswire/ -- Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense announced today that Kineta's management team has been invited to participate at Cowen and Company 40th Annual Health Care Conference in Boston, MA.  Shawn Iadonato, Kineta Chief Executive Officer, will provide a corporate overview on Monday, March 2nd at 2:00-2:25 PM, Eastern Time at the Boston Marriott Copley Place.  

Kineta, Inc. is a clinical stage biotechnology company committed to developing disruptive life science technologies that address unmet patient needs.  We have leveraged our expertise in immunology and innate immunity to advance a focused pipeline of investigational drugs in oncology, neuroscience and biodefense.  We actively collaborate with a broad array of private, government and industry partners to advance our innovative products.  For more information on Kineta visit our website, www.kinetabio.com, follow us on Twitter at @kinetabio, LinkedIn and Like us on facebook.com/KinetaBio 

NOTICE: This document contains certain forward-looking statements, including without limitation statements regarding Kineta's and its affiliates' plans for pre-clinical and clinical studies, regulatory filings, investor returns and anticipated drug effects in human subjects. You are cautioned that such forward-looking statements are not guarantees of future performance and involve risks and uncertainties inherent in Kineta's and its subsidiaries' businesses which could significantly affect expected results, including without limitation progress of drug development, ability to raise capital to fund drug development, clinical testing and regulatory approval, developments in raw material and personnel costs, and legislative, fiscal, and other regulatory measures. All forward-looking statements are qualified in their entirety by this cautionary statement, and neither Kineta nor its affiliates undertake any obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.

Contact:
Jacques Bouchy
234988@email4pr.com
(206) 378-0400

SOURCE Kineta, Inc.


These press releases may also interest you

at 14:55
In direct response to the Coronavirus pandemic, Industrial Magnetics, Inc.(IMI) has developed a new, hands-free door opener that allows people to open latch-less doors without using their fingers, arms, or clothing. The company has also announced...

at 14:45
James E. Wagner Cultivation Corporation ("JWC" or the "Corporation") , announced today that the Corporation and its subsidiaries (the "JWC Group") have obtained an initial order (the "Initial Order") from the Ontario Superior Court of Justice...

at 14:43
Maker Mask, a nonprofit initiative organized by leaders in technology, industry, and government, today announced significant and positive worldwide response to the group's designs for producing the Maker Mask, a medically reviewed and Open Source 3D...

at 14:35
The Prime Minister, Justin Trudeau, today announced the following change in the senior ranks of the Public Service: Dr. Harpreet S. Kochhar, currently Assistant Deputy Minister, Operations Sector, Immigration, Refugees and Citizenship Canada, becomes...

at 14:30
VMS BioMarketing ? a leading provider of patient support solutions ? announced it has more than doubled levels of virtual and telephonic patient engagement in the past week to support patients during the COVID-19 outbreak, using the company's...

at 14:30
ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced multiple options that enable trained healthcare professionals to advance respiratory clinical...



News published on 27 february 2020 at 08:37 and distributed by: